Esteban Arrieta‐Bolaños
- Transplantation top 5%
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 13
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 3
- Immunology top 10%
- T-cell and B-cell Immunology 30
- Immune Cell Function and Interaction 25
- Immunotherapy and Immune Responses 8
-
- Cytomegalovirus and herpesvirus research 6
-
- vaccines and immunoinformatics approaches 13
Esteban Arrieta‐Bolaños
44 papers receiving 348 citations
Peers
Comparison fields: 5 of 59
- Transplantation 62
- Hematology 162
- Immunology 217
- Oncology 46
- Epidemiology 50
Countries citing papers authored by Esteban Arrieta‐Bolaños
This map shows the geographic impact of Esteban Arrieta‐Bolaños's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Arrieta‐Bolaños with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Arrieta‐Bolaños more than expected).
Fields of papers citing papers by Esteban Arrieta‐Bolaños
This network shows the impact of papers produced by Esteban Arrieta‐Bolaños. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Arrieta‐Bolaños. The network helps show where Esteban Arrieta‐Bolaños may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esteban Arrieta‐Bolaños, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 40 | |
| 8 | 2020 | 32 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 2 | |
| 16 | 2014 | 9 | |
| 17 | 2012 | 5 | |
| 18 | 2010 | 1 | |
| 19 | 2010 | 16 | |
| 20 | [Evaluation of the potential adulteration of commercial honey distributed in Costa Rica compared with artesanian honey samples coming from specific apiaries]. | 2007 | 3 |
About Esteban Arrieta‐Bolaños
Esteban Arrieta‐Bolaños is a scholar working on Hematology, Immunology and Transplantation, having authored 47 papers that have together received 355 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (25 papers), vaccines and immunoinformatics approaches (13 papers), Hematopoietic Stem Cell Transplantation (13 papers), Immunotherapy and Immune Responses (8 papers), Cytomegalovirus and herpesvirus research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Transplantation (62 citations), Hematology (162 citations) and Immunology (217 citations). Esteban Arrieta‐Bolaños has collaborated with scholars based in Germany, United States and Mexico. Frequent co-authors include Rodrigo Barquera, Katharina Fleischhauer, Pietro Crivello, Diana Iraíz Hernández-Zaragoza, J. Alejandro Madrigal, Bronwen E. Shaw, Steven G. E. Marsh, J.H. Frederik Falkenburg, Dietrich W. Beelen and Stephen R. Spellman. Their work appears in journals such as Human Immunology, Blood, Frontiers in Immunology, The Journal of Immunology and HLA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.